{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.2385G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "2385"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "2385"
          },
          "Description in input context": "c.2385G>A (p.Gly2385Arg)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0001473"
  },
  "Experiment Method": [
    {
      "Assay Method": "Transfection in human cell lines",
      "Material used": {
        "Material Source": "Human cell lines",
        "Material Name": "Not specified",
        "Description": "Human cell lines were transfected with wild-type and Gly2385Arg LRRK2 constructs."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.2385G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Gly2385Arg variant showed increased toxicity and higher apoptosis rates under oxidative stress compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not explicitly mentioned, but p-values were provided."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal protein expression levels under basal conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly reduced cell viability under oxidative stress.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "This method is commonly used to study the effects of genetic variants in Parkinson's disease."
      }
    }
  ]
}